Protective immunity to Listeria monocytogenes elicited by immunization with heat-killed Listeria and IL-12. Potential mechanism of IL-12 adjuvanticity

Annals of the New York Academy of Sciences

Volumn 797, Issue , 1996, Pages 207-227

  Miller, Mark A ^a   Skeen, Marianne J ^a   Ziegler, H Kirk ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INACTIVATED VIRUS VACCINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; CELL ACTIVATION; CELLULAR IMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; LISTERIA MONOCYTOGENES; LISTERIOSIS; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHENOTYPE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALIA; BACTERIA (MICROORGANISMS); LISTERIA; LISTERIA MONOCYTOGENES; LISTERIOSIS MONOCYTOGENES;

EID: 0030450508     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb52962.x     Document Type: Conference Paper

References (72)

1. BURKE, K. L., G. DUNN, M. FERGUSON, P. D. MINOR & J. W. ALMOND. 1988. Antigen chimeras of poliovirus as potential new vaccines. Nature 332: 81.
2. CURTISS, R. I., S. M. KELLY, P. A. GULIG & K. NAKAYAMA. 1989. Selective delivery of antigens by recombinant bacteria. Curr. Top. Micriobiol. Immunol. 146: 45.
3. CASTEN, L. A., P. KAUMAYA & S. K. PIERCE. 1988. Enhanced T cell responses to antigenic peptides targeted to B cell surface Ig, Ia, or class I molecules. J. Exp. Med. 168: 171.
4. CARAYANNIOTIS, G. & B. H. BARBER. 1987. Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC. Nature 327: 59.
5. CARAYANNIOTIS, G., E. VIZI, J. M. PARKER, R. S. HODGES & B. H. BARBER. 1988. Delivery of synthetic peptides by anti-class II MHC monoclonal antibodies induces specific adjuvant-free IgG responses in vivo. Molec. Immunol. 25: 907.
6. CARAYANNIOTIS, G. & B. H. BARBER. 1990. Characterization of the adjuvant-free serological response to protein antigens coupled to antibodies specific for class II MHC determinants. Vaccine 8: 137.
7. COOPER, P. D. 1985. Complement and cancer: Activation of the alternative pathway as a theoretical basis for immunotherapy. Adv. Immunol. Cancer Therapy 1: 125.
8. COOPER, P. D. & E. J. STEELE. 1988. The adjuvanticity of gamma-inulin. Immunol. Cell Biol. 66: 345.
9. MCGHEE, J. R., J. MESTECKY, C. O. ELSON & H. KIYONO. 1989. Regulation of IgA synthesis and immune response by T cells and interleukins. J. Clin. Immunol. 9: 175.
10. MCGHEE, J. & J. MESTECKY. 1990. In defense of mucosal surfaces. Development of novel vaccines for IgA responses at the portals of entry of microbial pathogens. Infect. Dis. Clin. North Am. 4: 315.
11. KAWAMURA, H., S. A. ROSENBERG & J. A. BERZOFSKY. 1985. Immunization with antigen and interleukin 2 in vivo overcomes Ir gene low responsiveness. J. Exp. Med 162: 381.
12. LEBMAN, D. A., F. D. LEE & R. L. COFFMAN. 1990. Mechanism for transforming growth factor B and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated murine B lymphocytes. J. Immunol. 144: 952.
13. MEUER, S. C., H. DUMANN, K. H. MEYER ZUM BUSCHENFELD & H. KOHLER. 1989. Low-dose interleukin 2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination. Lancet 1: 15.
14. MURRAY, P. D., D. T. MCKENZIE, S. L. SWAIN & M. F. KAGNOFF. 1987. Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression. J. Immunol. 139: 2669.
15. ROUSE, B. T., L. S. MILLER, L. TURTINEN & R. N. MOORE. 1985. Augmentation of immunity to herpes simplex virus by in vivo administration of interleukin 2. J. Immunol. 134: 926.
16. SNAPPER, C. M. & W. E. PAUL. 1987. Interferon-gamma and B cell stimulatory factor-I reciprocally regulate Ig isotype production. Science 236: 944.
17. KOBAYASHI, M., L. FITZ, M. RYAN, R. M. HEWICK, S. C. CLARK, S. CHAN, R. LOUDON, F. SHERMAN, B. PERUSSIA & G. TRINCHIERI. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J. Exp. Med. 170: 827.
18. D'ANDREA, A., M. RENGARAJU, N. M. VALIANTE, J. CHEHIMI, M. KUBIN, M. ASTE, S. H. CHAN, M. KOBAYASHI, D. YOUNG, E. NICKBARG, R. CHIZZONITE, S. F. WOLF & G. TRINCHIERI. 1992. Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells. J. Exp. Med. 176: 1387.
19. GATELY, M. K., B. B. DESAI, A. G. WOLITZKY, P. M. QUINN, C. M. DWYER, F. J. PODLASKI, P. C. FAMILLETTI, F. SINIGAGLIA, R. CHIZONNITE, U. GUBLER & A. S. STERN. 1991. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol. 147: 874.
20. ROBERTSON, M. J., R. J. SOIFFER, S. F. WOLF, T. J. MANLEY, C. DONAHUE, D. YOUNG, S. H. HERRMANN & J. RITZ. 1992. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): Cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med. 175: 779.
21. BERTAGNOLLI, M. M., B. Y. LIN, D. YOUNG & S. H. HERRMANN. 1992. IL-12 augments antigen-dependent proliferation of activated T lymphocytes. J. Immunol. 149: 3778.
22. + T lymphocytes, and NK cells. J. Immunol. 149: 3495.
23. CHAN, S. H., B. PERUSSIA, J. W. GUPTA, M. KOBAYASHI, M. POSPISIL, H. A. YOUNG, S. F. WOLF, D. YOUNG, S. C. CLARK AND G. TRINCHIERI. 1991. Induction of interferon gamma production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173: 869.
24. CHAN, S. H., M. KOBAYASHI, D. SANTOLI, B. PERUSSIA & G. TRINCHIERI. 1992. Mechanisms of IFN-gamma induction by natural killer cell stimulatory factor (NKSF/IL-12). Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J. Immunol. 148: 92.
25. GAZZINELLI, R. T., S. HIENY, T. A. WYNN, S. WOLF & A. SHER. 1993. Interleukin-12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90: 6115.
26. TRIPP, C. S., S. F. WOLF & E. R. UNANUE. 1993. Interleukin-12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90: 3725.
27. ZIEGLER, H. K., M. J. SKEEN & K. M. PEARCE. 1994. Role of α/β and γ/δ cells in innate and acquired immunity. In Microbial Pathogenesis and Immune Response. E. W. Ades, R. F. Rest & S. A. Morse, Eds. Ann. N.Y. Acad. Sci. 730: 53.
28. SKEEN, M. J. & H. K. ZIEGLER. 1994. Activation of γ/δ T cells for production of IFN-γ is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-12. J. Immunol. 154: 5832.
29. GATELY, M. K., A. G. WOLITZKY, P. M. QUINN & R. CHIZZONITE. 1992. Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell. Immunol. 143: 127.
30. TRINCHIERI, G. 1993. Interleukin-12 and its role in the generation of Th1 cells. Immunol. Today 14: 335.
31. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547.
32. + T cells to enhance priming for interferon gamma production and diminishes interleukin-4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90: 10188.
33. MANETTI, R., P. PARRONCHI, M. G. GIUDIZI, M. P. PICCINNI, E. MAGGI, G. TRINCHIERI & S. ROMAGNANI. 1993. Natural killer cell stimulatory factor (interleukin-12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177: 1199.
34. HEINZEL, F. P., D. S. SCHOENHAUT, R. M. RERKO, L. E. ROSSER & M. K. GATELY. 1993. Recombinant interleukin-12 cures mice infected with Leishmania major. J. Exp. Med. 177: 1505.
35. SYPEK, J. P., C. L. CHUNG, S. E. MAYOR, J. M. SUBRAMANYAM, S. J. GOLDMAN, D. S. SIEBURTH, S. F. WOLF & R. G. SCHAUB. 1993. Resolution of cutaneous leishmaniasis: interleukin-12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177: 1797.
36. STEVENSON, M. M., M. F. TAM, S. F. WOLF & A. SHER. 1995. IL-12 induced protection against blood-stage Plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155: 2545.
37. WYNN, T. A., A. W. CHEEVER, D. JANKOVIC, R. W. POINDEXTER, P. CASPAR, F. A. LEWIS & A. SHER. 1995. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376: 594.
38. ORANGE, J. S., S. F. WOLF & C. A. BIRON. 1994. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152: 1253.
39. CLERICI, M., D. R. LUCEY, J. A. BERZOFSKY, L. A. PINTO, T. A. WYNN, S. P. BLATT, M. J. DOLAN, C. W. HENDRIX, S. F. WOLF & G. M. SHEARER. 1993. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 262: 1721.
40. TRIPP, C. S., M. K. GATELY, J. HAKIMI, P. LING & E. R. UNANUE. 1994. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. J. Immunol. 152: 1883.
41. AFONSO, L. C., T. M. SCHARTON, L. Q. VIEIRA, M. WYSOCKA, G. TRINCHIERI & P. SCOTT. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263: 235.
42. NORTH, R. J. 1973. Cellular mediators of anti-Listeria immunity as an enlarged population of short-lived replicating T cells. J. Exp. Med. 138: 342.
43. BARZA, M. 1985. Listeriosis in milk. N. Engl. J. Med. 312: 438.
44. GRAY, M. L. & A. H. KILLINGER. 1966. Listeria monocytogenes and listeric infections. Bacteriol. Rev. 30: 309.
45. SEELIGER, H. P. R. 1961. Listeriosis. Hafner. New York.
46. JURADO, R. L., M. M. FARLEY, E. PEREIRA, R. C. HARVEY, A. SCHUCHAT, J. D. WENGER & D. S. STEPHENS. 1993. Increased risk of Listeria monocytogenes meningitis and bacteremia in patients with human immunodeficiency virus infection. Clin Infect. Dis. 17: 224.
47. ZIEGLER, H. K. & E. R. UNANUE. 1981. Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes. J. Immunol. 127: 1869.
48. MACKANESS, G. B. 1962. Cellular resistance to infection. J. Exp. Med. 116: 381.
49. ROTHE, J., W. LESSLAUER, H. LOTSCHER, Y. LANG, P. KOEBEL, F. KONTGEN, A. ALTHAGE, R. ZINKERNAGEL, M. STEINMETZ & H. BLUETHMANN. 1993. Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptable to infection by Listeria monocytogenes. Nature 364: 798.
50. HUANG, S., W. HENDRIKS, A. ALTHAGE, S. HEMMI, H. BLUETHMANN, R. KAMIJO, J. VILCEK, R. M. ZINKERNAGEL & M. AQUET. 1993. Immune response in mice that lack the interferon-gamma receptor. Science 259: 1742.
51. SKEEN, M. J. & H. K. ZIEGLER. 1993. Intercellular interactions and cytokine responsiveness of peritoneal α/β and γ/δ T cells from Listeria-infected mice: Synergistic effects of interleukin-1 and 7 on γ/δ T cells. J. Exp. Med. 178: 985.
52. SKEEN, M. J. & H. K. ZIEGLER. 1993. Induction of murine peritoneal γ/δ T cells and their role in resistance to bacterial infection. J. Exp. Med. 178: 971.
53. MOMBAERTS, P. J. ARNOLD, F. RUSS, S. TONEGAWA & S. H. E. KAUFMANN. 1993. Different roles of α/β and γ/δ T cells in immunity against an intracellular bacterial pathogen. Nature 365: 53.
54. ARMSTRONG, A. S. & C. P. SWORD. 1964. Cellular resistance in listeriosis. J. Infect. Dis. 114: 258.
55. MACKANESS, G. B. & W. C. HILL. 1969. The effect of anti-lymphocyte globulin on cell-mediated resistance to infection. J. Exp. Med. 129: 993.
56. KAUFMANN, S. H. E., M. M. SHIMON & H. HAHN. 1979. Specific Lyt 123 T cells are involved in protection against Listeria monocytogenes and in delayed-type hyperensitivity to listerial antigens. J. Exp. Med. 150: 1033.
57. BERCHE, P., J. L. GAILLARD & P. J. SANSONETTI. 1987. Intracellular growth of L. monocytogenes as a prerequesite for in vivo induction of T cell immunity. J. Immunol. 138: 2266.
58. BUCHMEIER, N. A. & R. D. SCHREIBER. 1985. Requirement of endogenous interferon-γ production for resolution of Listeria monocytogenes infection. Proc. Natl. Acad. Sci. USA 82: 7404.
59. BERCHE, P., J. L. GAILLARD, C. GEOFFROY & J. E. ALOUF. 1987. T cell recognition of listeriolysin O is induced during infection with Listeria monocytogenes. J. Immunol. 139: 3813.
60. MITSUYAMA, M., K. IGARASHI, I. KAWAMURA, T. OHMORI & K. NOMOTO. 1990. Difference in the induction of macrophage interleukin-1 production between viable and killed cells of Listeria monocytogenes. Infect. Immun. 58: 1254.
61. WIRSING VON KOENIG, C. H., H. FINGER & H. HOF. 1982. Failure of killed Listeria monocytogenes vaccine to produce protective immunity. Nature (Lond) 297: 233.
62. MARSHALL, N. E. & H. K. ZIEGLER. 1991. The role of bacterial hemolysin production in induction of macrophage Ia expression during infection with Listeria monocytogenes. J. Immunol. 147: 2324.
63. SAFLEY, A. S., C. W. CLUFF, N. E. MARSHALL & H. K. ZIEGLER. 1991. Role of listeriolysin-O (LLO) in the T lymphocyte response to infection with Listeria monocytogenes: Identification of T cell epitopes of LLO. J. Immunol. 146: 3604.
64. WENTWORTH, P. A. & H. K. ZIEGLER. 1987. The antigenic and mitogenic response of murine B and T lymphocytes to soluble listerial proteins fractionated by preparative SDS-PAGE. J. Immunol. 138: 2671.
65. MARSHALL, N. E. & H. K. ZIEGLER. 1991. Lipopolysaccharide responsiveness is an important factor in the generation of antigen-specific T cell responses during infection with gram-negative bacteria. J. Immunol. 147: 2333.
66. MILLER, M. A., M. J. SKEEN & H. K. ZIEGLER. 1995. Non-viable bacterial antigens administered with IL-12 generate antigen-specific T cell responses and protective immunity against Listeria monocytogenes. J. Immunol. 155: 4817.
67. GREGORY, S. H., L. K. BARCZYNSKI & E. J. WING. 1992. Effector function of hepatocytes and Kupffer cells in the resolution of systemic bacterial infections. J. Leukocyte Biol. 51: 421.
68. VAN DIJK, H., F. M. HOFHUIS, E. M. BERNS, C. VAN DER MEER & J. M. WILLERS. 1980. Killed Listeria monocytogenes vaccine is protective in C3H/HeJ mice without addition of adjuvants. Nature 286: 713.
69. VAN DER MEER, C., F. M. HOFHUIS & J. M. WILLERS. 1977. Killed Listeria monocytogenes vaccine becomes protective on addition of polyanions. Nature 269: 594.
70. HASENCLEVER, H. F. & W. W. KARAKAWA. 1957. Immunization of mice against Listeria monocytogenes. J. Bacteriol. 74: 584.
71. + cells in antibacterial protection to facultative intracellular bacteria. J. Immunol. 134: 569.
72. SKEEN, M. J., M. A. MILLER, T. M. SHINNICK & H. K. ZIEGLER. 1996. Regulation of murine macrophage IL-12 production: activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. J. Immunol. 156: 1196-1206.